Capital Rx Inducted into the Inaugural Hall of Fame by Digital Health New York (DHNY)

After five years of making DHNY’s DHNY 100, Capital Rx named to the DHNY Hall of Fame

NEW YORK, Feb. 6, 2025 /PRNewswire/ — Capital Rx, Inc., the enterprise health technology company and benefit administrator advancing our nation’s electronic healthcare infrastructure, has been named to the inaugural Digital Health New York (DHNY) Hall of Fame. The new Hall of Fame celebrates 28 companies that have built the foundation of New York’s Digital Health ecosystem and has been published in conjunction with the 2025 New York Healthcare Innovation Report, which analyzes the digital health sector’s investment trends, challenges, and opportunities. 

“We are honored to be inducted into the inaugural DHNY Hall of Fame,” said Capital Rx Co-Founder and CEO AJ Loiacono. “Our roots are here in New York City, and we’re proud to call this city, which has become the health technology capital of America, our home. New York has a special blend of talent, resources, and community that has driven healthcare innovation to new heights.”

“The companies recognized in our Hall of Fame represent the very best in innovation and transformation in healthcare, driving progress that has strengthened the industry and significantly improved care delivery, experiences, and outcomes,” said Bunny Ellerin, CEO, DHNY. “We are excited to celebrate these visionary organizations that have shaped the foundation of New York’s dynamic digital health ecosystem.”

Capital Rx’s proprietary enterprise health platform, JUDI®, has set a new standard for pharmacy benefit administration software and operational efficiency in healthcare claim processing. Purpose-built from the ground up, JUDI consolidates all the necessary workflows in one user-friendly system, seamlessly exchanges data with 600+ organizations, and handles benefit customization requests and configurations for new regulations or requirements with relative ease, resulting in faster outputs and better outcomes for commercial Medicare, and Medicaid plans and their members.

Inaugural sponsors of the DHNY Hall of Fame are CFGI and Wilson Sonsini. To download a copy of the New York Healthcare Innovation Report, please click here.

About Digital Health New York (DHNY)
Digital Health New York (DHNY) is a connected community of digital health leaders who share ideas, spark new directions and create success across the entire ecosystem. As an organization, we seek to increase the visibility of New York City as a leader in healthcare innovation and showcase the companies and leaders creating the future of healthcare. Our flagship event, DHNY Summit, brings together an elite group of entrepreneurs, investors, payers, providers and executives to cultivate the New York digital health community and drive impactful conversations around the current and future state of digital health. DHNY was founded in 2022 in collaboration with AlleyCorp. For more information or to join DHNY’s mailing list, please visit www.dhny.co.

About Capital Rx
Capital Rx is a health technology company providing claim administration and technology solutions for carriers, health plans, TPAs, employer groups, and government entities. As a Certified B Corp™, Capital Rx is executing on its mission to materially reduce healthcare costs as a full-service PBM and through the deployment of JUDI^®, the company’s cloud-native enterprise health platform. JUDI connects every aspect of the healthcare ecosystem in one efficient, scalable platform, servicing millions of members for Medicare, Medicaid, and commercial plans. Together with its clients, Capital Rx is reimagining the administration of benefits and rebuilding trust in healthcare. To learn more, visit www.capitalrx.com. 

Media Contacts
Michael Passanante, SVP, Marketing & Communications
Justin Venneri, Director, Communications
marketing@cap-rx.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/capital-rx-inducted-into-the-inaugural-hall-of-fame-by-digital-health-new-york-dhny-302370472.html

SOURCE Capital Rx